Birch Hill Investment Advisors’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-6,100
Closed -$259K 162
2021
Q4
$259K Sell
6,100
-7,000
-53% -$294K 0.01% 158
2021
Q3
$568K Hold
13,100
0.03% 119
2021
Q2
$560K Hold
13,100
0.03% 115
2021
Q1
$506K Sell
13,100
-300
-2% -$11.4K 0.03% 114
2020
Q4
$482K Buy
13,400
+5,000
+60% +$180K 0.03% 110
2020
Q3
$321K Sell
8,400
-1,800
-18% -$69.4K 0.02% 122
2020
Q2
$358K Buy
10,200
+1,000
+11% +$36K 0.03% 114
2020
Q1
$300K Sell
9,200
-9,825
-52% -$384K 0.03% 110
2019
Q4
$860K Sell
19,025
-3,925
-17% -$164K 0.06% 94
2019
Q3
$934K Sell
22,950
-600
-3% -$25.4K 0.07% 91
2019
Q2
$1.01M Sell
23,550
-325
-1% -$12.5K 0.07% 87
2019
Q1
$916K Buy
23,875
+325
+1% +$12.4K 0.07% 85
2018
Q4
$832K Buy
23,550
+1,500
+7% +$54.4K 0.07% 86
2018
Q3
$849K Buy
22,050
+3,275
+17% +$114K 0.06% 94
2018
Q2
$614K Buy
18,775
+9,375
+100% +$283K 0.05% 102
2018
Q1
$257K Buy
+9,400
New +$255K 0.02% 127

Other funds holding BSX

Birch Hill Investment Advisors's BSX Position: Q1 2022 in Review

Birch Hill Investment Advisors sold out of Boston Scientific (BSX) in Q1 2022, closing a stake of 6,100 shares — an estimated $259K sold.

Birch Hill Investment Advisors first reported a position in BSX in Q1 2018 and held it in 16 quarters. The position peaked at $1.01M in Q2 2019. 904 funds tracked by Wall St. Rank hold BSX as of Q1 2022.

  • Birch Hill Investment Advisors reported no remaining Boston Scientific position as of Q1 2022 after selling out during the quarter.
  • Birch Hill Investment Advisors sold 6,100 Boston Scientific shares in Q1 2022, an estimated $259K.
  • Birch Hill Investment Advisors first reported a position in Boston Scientific in Q1 2018 and held it in 16 quarters.
  • Birch Hill Investment Advisors's Boston Scientific position peaked at $1.01M in Q2 2019.
  • 904 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2022.

Based on Birch Hill Investment Advisors's 13F filing for Q1 2022, filed 8 Apr 2022.